RNA Interference Market - Forecast(2021 - 2026)

Report Code: HCR 62940 Report Format: PDF + Excel (Delivery in 48 Hrs)
RNA Interference Market Overview

RNA Interference Market size was $9.44Bn in 2019, growing at a CAGR of 16.5% during the forecast period 2020-2025. RNA Interference is a conserved biological process to double-stranded RNA that mediates resistance to endogenous parasitic and exogenous pathogenic nucleic acids and regulates protein coding genes. It is used in studying gene functions as it allows sequence specific gene suppression in eukaryotic organisms and cultured cells. It is a mechanism of silencing gene expression after the gene has been transcribed owing to the presence of anti-sense RNA and targets mRNA. It is process of treating forms of cancer and other diseases by post-transcriptional silencing of genes (Caenorhabditis elegans) by small fragments of the nucleic acid.

Report Coverage
The report: “RNA Interference Market – Forecast (2020-2025)”, by IndustryARC covers an in-depth analysis of the following segments of the RNA Interference Market.

Key Takeaways
Increased research in the field of RNA therapeutics is set to propel the growth of the market.
Increasing genetic and metabolic disorders including diseases like cancer and Cardiology worldwide drives the market’s growth.
Europe region is estimated to record the fastest growth rate during the forecast period 2020-2025.

By Drug Delivery Type - Segment Analysis

In 2019, Nano Particle Drug Deliverysegment dominated the RNA Interference Market in terms of revenue is estimated to grow at a CAGR of 11.4%. It is used for the treatment of cardiovascular diseases, cancer, and others by passing the nano particles into the genes. The nano particles are wangled to get attracted towards the diseased cells for the direct treatment of cancerous cells. Drug delivery devices offer direct delivery to the site of therapy, improving treatment outcomes while reducing side effects and overall associated healthcare costs abetting towards the market’s growth.

Geography - Segment Analysis

In 2019, the North America region dominated RNA Interference Market in terms of revenue with a market share of 36%owing towards the increase ofRNA Interference. This growth can be attributed towards the increasing cases of oncology, cardiology, genetic disorders and others in this region. Government has taken initiatives to promote technological advancements in this region are key factors in the growth of the RNA Interference market.Asia Pacific is estimated to record the fastest growth rate during the forecast period 2020-2025. 

Drivers – RNA Interference Market

Increase In The Improvement of RNA Delivery
Increase of safety regulations by the Government for food industries drive the RNA Interference Market. Increase in the genetic and metabolic disorders including diseases like cancer, cardiology and increasing applications in molecular diagnostics is driving the market’s growth.The aptamer drug delivery is the second most used type offering several advantages compared to protein and small-molecule drugs, such as low risk of side-effects and complications in humans and enhanced their drug like properties including improved stability and residence time in the bloodstream is the other major factor driving growth of the RNA Interference market. 

Challenges – RNA Interference Market

Government Regulations
The lack of proficient organization for RNA Interference system and growing stringent government policy and regulation toward market growth is restraining growth of the market.Increase of safety regulations by the Government for healthcare industries drive the RNA Interference Market. Government rules on RNAiare immunogenic and inherently unstable, which causes major problems for the research and development of drugs are restraining the growth of the market.

RNA Interference Industry Outlook
Product Launches was the key strategy of the players in the RNA Interference Industry. RNA Interference top 10companiesincludeMerck & Co. Inc., Quark Pharmaceuticals Inc., Silence Therapeutics plc, Tacere Therapeutics Inc., PhaseRx Inc., Sirnaomics Inc., Access Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., Phio Pharmaceuticals Corporation and Thermo Fisher Scientific Inc.

Acquisitions/Product Launches

  • In October 2019,Thermo Fisher Scientific Inc.launched Cell Culture Media. It provides a flexible alternative for biological researchers that also save energyto enable our customers to make the world healthier, cleaner and safer. 
  •  In January 2020, Merck & Co. Inc. acquired Zedi’s ArQule, Inc. This acquisition helped the company inincreasing the production.

1. RNA Interference Market Overview
    1.1 Definitions and Scope
2. RNA Interference Market - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Drug Delivery Type
    2.3 Key trends by Treatment Type
    2.4 Key trends by Geography
3. RNA Interference Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis
4. RNA Interference Market - Startup Companies Scenario (Premium)
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. RNA Interference Market – Industry Market Entry Scenario Premium (Premium)
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. RNA Interference Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters Five Force Model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes 
7. RNA Interference Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. RNA Interference Market – By Drug Delivery Type (Market Size –$Million/$Billion)
    8.1 Nanoparticle Drug Delivery
    8.2 Pulmonary Drug Delivery
    8.3 Aptamer Drug Delivery
    8.4 Nucleic Acid Drug Delivery
    8.5 Others
9. RNA Interference Market – By Treatment Type (Market Size –$Million/$Billion)
    9.1 Oncology
    9.2 Infectious Diseases
    9.3 Genetic Disorders
    9.4 Ophthalmic Diseases
    9.5 Neurology
    9.6 Cardiology
    9.7 Metabolic Disorders
    9.8 Others
10. RNA Interference Market – By End User (Market Size –$Million/$Billion)
    10.1 Hospitals/Clinics
    10.2 Researchers
    10.3 Pharmaceuticals
    10.4 Others
11. RNA Interference Market - By Geography (Market Size –$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Canada
        11.1.3 Mexico
    11.2 Europe
        11.2.1 U.K.
        11.2.2 Germany
        11.2.3 France
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Denmark
        11.2.7 Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 India
        11.3.3 Japan
        11.3.4 South Korea
        11.3.5 Australia & New Zealand
        11.3.6 Malaysia
        11.3.7 Rest of Asia-Pacific
    11.4 Rest of the World
        11.4.1 Middle East
        11.4.2 Africa
        11.4.3 South America
12. RNA Interference Market - Entropy
13. RNA Interference Market – Industry/Segment Competition Landscape (Premium)
    13.1 Market Share Analysis
        13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key companies
        13.1.3 Market Share by Countries – Key Companies
        13.1.4 Best Practices for Companies
14. RNA Interference Market – Key Company List by Country Premium (Premium)
15. RNA Interference Market Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10 and more
"*Financials for private companies would be provided on a best efforts basis”.

LIST OF TABLES

1.Global Rnai Drug Delivery Market, By Drug Delivery Technology Market 2019-2024 ($M)
1.1 Nanoparticle Drug Delivery Technology Market 2019-2024 ($M) - Global Industry Research
1.2 Pulmonary Drug Delivery Technology Market 2019-2024 ($M) - Global Industry Research
1.3 Nucliec Acid Drug Delivery Technology Market 2019-2024 ($M) - Global Industry Research
1.4 Aptamer Drug Delivery Technology Market 2019-2024 ($M) - Global Industry Research
2.Global Rnai Drug Delivery Market, By Drug Delivery Technology Market 2019-2024 (Volume/Units)
2.1 Nanoparticle Drug Delivery Technology Market 2019-2024 (Volume/Units) - Global Industry Research
2.2 Pulmonary Drug Delivery Technology Market 2019-2024 (Volume/Units) - Global Industry Research
2.3 Nucliec Acid Drug Delivery Technology Market 2019-2024 (Volume/Units) - Global Industry Research
2.4 Aptamer Drug Delivery Technology Market 2019-2024 (Volume/Units) - Global Industry Research
3.North America Rnai Drug Delivery Market, By Drug Delivery Technology Market 2019-2024 ($M)
3.1 Nanoparticle Drug Delivery Technology Market 2019-2024 ($M) - Regional Industry Research
3.2 Pulmonary Drug Delivery Technology Market 2019-2024 ($M) - Regional Industry Research
3.3 Nucliec Acid Drug Delivery Technology Market 2019-2024 ($M) - Regional Industry Research
3.4 Aptamer Drug Delivery Technology Market 2019-2024 ($M) - Regional Industry Research
4.South America Rnai Drug Delivery Market, By Drug Delivery Technology Market 2019-2024 ($M)
4.1 Nanoparticle Drug Delivery Technology Market 2019-2024 ($M) - Regional Industry Research
4.2 Pulmonary Drug Delivery Technology Market 2019-2024 ($M) - Regional Industry Research
4.3 Nucliec Acid Drug Delivery Technology Market 2019-2024 ($M) - Regional Industry Research
4.4 Aptamer Drug Delivery Technology Market 2019-2024 ($M) - Regional Industry Research
5.Europe Rnai Drug Delivery Market, By Drug Delivery Technology Market 2019-2024 ($M)
5.1 Nanoparticle Drug Delivery Technology Market 2019-2024 ($M) - Regional Industry Research
5.2 Pulmonary Drug Delivery Technology Market 2019-2024 ($M) - Regional Industry Research
5.3 Nucliec Acid Drug Delivery Technology Market 2019-2024 ($M) - Regional Industry Research
5.4 Aptamer Drug Delivery Technology Market 2019-2024 ($M) - Regional Industry Research
6.APAC Rnai Drug Delivery Market, By Drug Delivery Technology Market 2019-2024 ($M)
6.1 Nanoparticle Drug Delivery Technology Market 2019-2024 ($M) - Regional Industry Research
6.2 Pulmonary Drug Delivery Technology Market 2019-2024 ($M) - Regional Industry Research
6.3 Nucliec Acid Drug Delivery Technology Market 2019-2024 ($M) - Regional Industry Research
6.4 Aptamer Drug Delivery Technology Market 2019-2024 ($M) - Regional Industry Research
7.MENA Rnai Drug Delivery Market, By Drug Delivery Technology Market 2019-2024 ($M)
7.1 Nanoparticle Drug Delivery Technology Market 2019-2024 ($M) - Regional Industry Research
7.2 Pulmonary Drug Delivery Technology Market 2019-2024 ($M) - Regional Industry Research
7.3 Nucliec Acid Drug Delivery Technology Market 2019-2024 ($M) - Regional Industry Research
7.4 Aptamer Drug Delivery Technology Market 2019-2024 ($M) - Regional Industry Research

LIST OF FIGURES

1.US RNA Interference Market Revenue, 2019-2024 ($M)
2.Canada RNA Interference Market Revenue, 2019-2024 ($M)
3.Mexico RNA Interference Market Revenue, 2019-2024 ($M)
4.Brazil RNA Interference Market Revenue, 2019-2024 ($M)
5.Argentina RNA Interference Market Revenue, 2019-2024 ($M)
6.Peru RNA Interference Market Revenue, 2019-2024 ($M)
7.Colombia RNA Interference Market Revenue, 2019-2024 ($M)
8.Chile RNA Interference Market Revenue, 2019-2024 ($M)
9.Rest of South America RNA Interference Market Revenue, 2019-2024 ($M)
10.UK RNA Interference Market Revenue, 2019-2024 ($M)
11.Germany RNA Interference Market Revenue, 2019-2024 ($M)
12.France RNA Interference Market Revenue, 2019-2024 ($M)
13.Italy RNA Interference Market Revenue, 2019-2024 ($M)
14.Spain RNA Interference Market Revenue, 2019-2024 ($M)
15.Rest of Europe RNA Interference Market Revenue, 2019-2024 ($M)
16.China RNA Interference Market Revenue, 2019-2024 ($M)
17.India RNA Interference Market Revenue, 2019-2024 ($M)
18.Japan RNA Interference Market Revenue, 2019-2024 ($M)
19.South Korea RNA Interference Market Revenue, 2019-2024 ($M)
20.South Africa RNA Interference Market Revenue, 2019-2024 ($M)
21.North America RNA Interference By Application
22.South America RNA Interference By Application
23.Europe RNA Interference By Application
24.APAC RNA Interference By Application
25.MENA RNA Interference By Application
26.Tekmira Pharmaceutical Corp, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Alnylam Pharmaceutical Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Merck Co Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Isi Pharmaceuticals, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Access Pharmaceutical Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Dicerna Pharmaceutical Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Calondo Pharmaceutical Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Marina Biotech Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Rxi Pharmaceutical Corp, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Quark Pharmaceutical Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)